Kappa - B.1.617.1

WHO Designation
Formerly Monitored Variant

Alternative names
G/452R.V3, Indian Variant, Kappa

First publication
Cherian et al, BioRxiv (May 2021)

Reference sequences given in literature
GISAID sequences based on mutations given at SARS-CoV-2 Variant Classifications and Definitions of CDC - U.S. Department of Health & Human Services

Sequence used for library generation
EPI_ISL_1372093 (Gisaid accession ID)

JPT’s products
PepMix™ SARS-CoV-2 (S-RBD B.1.617.1 / Kappa) : Spike receptor binding domain

Mutations in spike glycoprotein
T0095I, G0142D, E0154K, L0452R, E0484Q, D0614G, P0681R, Q1071H

Check our list of products, click and go.

Get a quote